Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 48.31M shares outstanding
USFilana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
Claude Nicaise, M.D.
Chairman of the Board and Class II Director
Dawn C. Bir
Class I Director
Eric J. Schoen
Chief Financial Officer
Michael J. O’Donnell, Esq.
Class I Director
Employees
19
Country
US
Sector
Healthcare
Website
filanatx.com
Loading congressional disclosures…
based on 48.31M shares outstanding
US30d Avg
5.84M
60d Avg
2.97M
90d Avg
2.06M
